Peptonic Medical AB (publ) today announced that the application to patent its intimate cleanser in US will be approved on June 20th2023, this according to information from the USPTO (United States Patent and Trademark Office).
“This is an important step to increase the attractiveness of our portfolio in the eyes of consumers and distribution partners in the US”, says Erik Sundquist, CEO of Peptonic Medical
The global intimate cleanser market is ca 1.2 billion USD growing at an annual rate of ca 3,5%. Somewhat simplified the market constitutes of soaps and oils. With soaps there is a risk of disturbing the vaginal microflora possibly leading to dryness and vaginal infections, with oils there is a challenge to cleanse water soluble impurities. Peptonics intimate cleanser is positioned in between. Based on the company’s clinically proven vaginal gel and a Nordic botanical oil VagiVital Moisturizing V Cleanser allows cleansing of both water and oil soluble impurities without disturbing the microflora. In parallel Peptonics patented cleanser moisturizes the intimate area and it is recommended by gynecologists.
“The intimate cleanser is an important part of our diagnose, treat and prevent concept. As it moisturizes at the same time it cleanses without disturbing the vaginal microflora it works preventively. The patent approval will allow us to further differentiate our offer in the market”, says Erik Sundquist
Erik Sundquist, CEO
Telefon: + 46 722 49 90 43
E-post: erik.sundquist@peptonicmedical.se
About Peptonic Medical AB
Peptonic is a Swedish innovative biomedical company that conducts research, development and sales of medical treatments and lifestyle products in the field of women’s health. Peptonic has divided its operations into two business areas: “Medical Consumer” and “Lifestyle Consumer”. The business area “Medical Consumer” is based on clinically proven intimate self-care and constitutes the company’s main focus and is sold under the VagiVital brand. The “Lifestyle Consumer” business area consists of lifestyle products with a focus on sustainable menstrual products and is sold under the Lunette brand. The company was founded in 2009 and the stock has been traded since 2014 on Spotlight (www.spotlightstockmarket.com) in Stockholm. More information about Peptonic Medical is available on www.peptonicmedical.se.
